NO953370L - Anvendelse av riluzol ved behandling av neuro-AIDS - Google Patents
Anvendelse av riluzol ved behandling av neuro-AIDSInfo
- Publication number
- NO953370L NO953370L NO953370A NO953370A NO953370L NO 953370 L NO953370 L NO 953370L NO 953370 A NO953370 A NO 953370A NO 953370 A NO953370 A NO 953370A NO 953370 L NO953370 L NO 953370L
- Authority
- NO
- Norway
- Prior art keywords
- riluzole
- neuro
- aids
- treatment
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9302568A FR2702148B1 (fr) | 1993-03-05 | 1993-03-05 | Application d'anticonvulsivants dans le traitement du neuro-sida. |
PCT/FR1994/000208 WO1994020103A1 (fr) | 1993-03-05 | 1994-02-25 | Application du riluzole dans le traitement du neuro-sida |
Publications (3)
Publication Number | Publication Date |
---|---|
NO953370L true NO953370L (no) | 1995-08-28 |
NO953370D0 NO953370D0 (no) | 1995-08-28 |
NO307687B1 NO307687B1 (no) | 2000-05-15 |
Family
ID=9444690
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953370A NO307687B1 (no) | 1993-03-05 | 1995-08-28 | Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS |
NO953372A NO953372L (no) | 1993-03-05 | 1995-08-28 | Anvendelse av lamotrigin ved behandling av neuro-AIDS |
NO953371A NO953371L (no) | 1993-03-05 | 1995-08-28 | Anvendelse av anti-konvulsiva ved behandling av neuro-AIDS |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953372A NO953372L (no) | 1993-03-05 | 1995-08-28 | Anvendelse av lamotrigin ved behandling av neuro-AIDS |
NO953371A NO953371L (no) | 1993-03-05 | 1995-08-28 | Anvendelse av anti-konvulsiva ved behandling av neuro-AIDS |
Country Status (23)
Country | Link |
---|---|
US (2) | US5629312A (no) |
EP (3) | EP0687177B1 (no) |
JP (3) | JPH08507508A (no) |
KR (3) | KR100318168B1 (no) |
AT (2) | ATE147981T1 (no) |
AU (3) | AU675118B2 (no) |
CA (3) | CA2154573A1 (no) |
CZ (3) | CZ284423B6 (no) |
DE (2) | DE69427344T2 (no) |
DK (2) | DK0687176T3 (no) |
ES (2) | ES2157252T3 (no) |
FR (1) | FR2702148B1 (no) |
GR (2) | GR3022356T3 (no) |
HU (3) | HU217132B (no) |
IL (3) | IL108846A0 (no) |
NO (3) | NO307687B1 (no) |
PL (3) | PL310474A1 (no) |
PT (1) | PT687176E (no) |
RU (1) | RU2157205C2 (no) |
SK (3) | SK107595A3 (no) |
UA (1) | UA41355C2 (no) |
WO (3) | WO1994020110A1 (no) |
ZA (2) | ZA941530B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866597A (en) * | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
DE19603984A1 (de) * | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
US20020022056A1 (en) | 1997-02-14 | 2002-02-21 | Burkhard Schlutermann | Oxacarbazepine film-coated tablets |
US5922746A (en) * | 1997-03-27 | 1999-07-13 | Allergan | Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
GB9721497D0 (en) * | 1997-10-09 | 1997-12-10 | Ciba Geigy Ag | Organic compounds |
FR2774592B1 (fr) * | 1998-02-06 | 2000-03-17 | Rhone Poulenc Rorer Sa | Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet |
FR2774908B1 (fr) * | 1998-02-17 | 2000-06-23 | Centre Nat Rech Scient | Utilisation d'inhibiteur de la liberation du glutamate dans le traitement de l'ischemie retinienne |
FR2787028B1 (fr) * | 1998-12-15 | 2002-10-18 | Aventis Pharma Sa | Utilisation du riluzole dans le traitement des traumatismes acoustiques |
AU4424500A (en) * | 1999-04-29 | 2000-11-17 | Centre National De La Recherche Scientifique (C.N.R.S.) | A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping |
US7479498B2 (en) | 1999-08-23 | 2009-01-20 | Phoenix Biosciences, Inc. | Treatments for viral infections |
GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
FR2801217B1 (fr) * | 1999-11-24 | 2002-12-06 | Aventis Pharma Sa | Association de riluzole et de gabapentine et son utilisation comme medicament |
GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
CA2471666C (en) | 2004-06-18 | 2009-10-13 | Apotex Pharmachem Inc. | An improved process for the preparation of oxcarbazepine and related intermediates |
EP2201963B1 (en) * | 2005-04-05 | 2016-01-27 | Yale University | Glutamate modulating agents in the treatment of mental disorders |
US20060252745A1 (en) * | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
FR2910811B1 (fr) * | 2007-01-03 | 2009-07-10 | Ass Pour Le Dev De La Biothera | Utilisation du riluzole et de ses derives pour fabriquer de nouveaux medicaments |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
FR2957077B1 (fr) * | 2010-03-02 | 2012-04-13 | Univ Dauvergne Clermont I | Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux |
DK3220891T3 (da) * | 2014-11-21 | 2019-11-04 | Biohaven Therapeutics Ltd | Sublingual formulering af riluzol |
WO2022183174A1 (en) * | 2021-02-24 | 2022-09-01 | Valvoline Licensing And Intellectual Property Llc | Foaming evaporator coil cleaner |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492258A1 (fr) * | 1980-10-17 | 1982-04-23 | Pharmindustrie | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole |
US4431641A (en) * | 1980-10-17 | 1984-02-14 | Ciba-Geigy Corporation | Pharmaceutical compositions having antiepileptic and antineuralgic action |
GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
US4826860A (en) * | 1987-03-16 | 1989-05-02 | Warner-Lambert Company | Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents |
US4918090A (en) * | 1988-01-25 | 1990-04-17 | Warner-Lambert Company | Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents |
EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
JPH07308499A (ja) * | 1994-05-20 | 1995-11-28 | Brother Ind Ltd | 衣類乾燥機 |
-
1993
- 1993-03-05 FR FR9302568A patent/FR2702148B1/fr not_active Expired - Lifetime
-
1994
- 1994-02-25 EP EP94908376A patent/EP0687177B1/fr not_active Expired - Lifetime
- 1994-02-25 PL PL94310474A patent/PL310474A1/xx unknown
- 1994-02-25 KR KR1019950703732A patent/KR100318168B1/ko not_active IP Right Cessation
- 1994-02-25 JP JP6519648A patent/JPH08507508A/ja active Pending
- 1994-02-25 EP EP94908374A patent/EP0687176B1/fr not_active Expired - Lifetime
- 1994-02-25 ES ES94908374T patent/ES2157252T3/es not_active Expired - Lifetime
- 1994-02-25 WO PCT/FR1994/000209 patent/WO1994020110A1/fr not_active Application Discontinuation
- 1994-02-25 CA CA002154573A patent/CA2154573A1/fr not_active Abandoned
- 1994-02-25 HU HU9502585A patent/HU217132B/hu not_active IP Right Cessation
- 1994-02-25 AU AU61437/94A patent/AU675118B2/en not_active Ceased
- 1994-02-25 RU RU95121731/14A patent/RU2157205C2/ru not_active IP Right Cessation
- 1994-02-25 AT AT94908376T patent/ATE147981T1/de active
- 1994-02-25 PL PL94310476A patent/PL310476A1/xx unknown
- 1994-02-25 HU HU9502583A patent/HUT73434A/hu unknown
- 1994-02-25 AT AT94908374T patent/ATE201597T1/de active
- 1994-02-25 PL PL94310475A patent/PL310475A1/xx unknown
- 1994-02-25 AU AU61438/94A patent/AU6143894A/en not_active Abandoned
- 1994-02-25 DE DE69427344T patent/DE69427344T2/de not_active Expired - Lifetime
- 1994-02-25 UA UA95083996A patent/UA41355C2/uk unknown
- 1994-02-25 EP EP94908375A patent/EP0687179A1/fr not_active Withdrawn
- 1994-02-25 CA CA002154571A patent/CA2154571A1/fr not_active Abandoned
- 1994-02-25 ES ES94908376T patent/ES2096455T3/es not_active Expired - Lifetime
- 1994-02-25 SK SK1075-95A patent/SK107595A3/sk unknown
- 1994-02-25 CZ CZ952261A patent/CZ284423B6/cs unknown
- 1994-02-25 CZ CZ952260A patent/CZ226095A3/cs unknown
- 1994-02-25 DK DK94908374T patent/DK0687176T3/da active
- 1994-02-25 SK SK1076-95A patent/SK279659B6/sk not_active IP Right Cessation
- 1994-02-25 WO PCT/FR1994/000208 patent/WO1994020103A1/fr active IP Right Grant
- 1994-02-25 DK DK94908376.0T patent/DK0687177T3/da active
- 1994-02-25 SK SK1074-95A patent/SK107495A3/sk unknown
- 1994-02-25 JP JP51964794A patent/JP3578174B2/ja not_active Expired - Fee Related
- 1994-02-25 KR KR1019950703734A patent/KR960700721A/ko not_active Application Discontinuation
- 1994-02-25 CA CA002154572A patent/CA2154572C/fr not_active Expired - Fee Related
- 1994-02-25 US US08/530,253 patent/US5629312A/en not_active Expired - Fee Related
- 1994-02-25 PT PT94908374T patent/PT687176E/pt unknown
- 1994-02-25 DE DE69401577T patent/DE69401577T2/de not_active Expired - Fee Related
- 1994-02-25 HU HU9502584A patent/HU9502584D0/hu unknown
- 1994-02-25 AU AU61439/94A patent/AU675119B2/en not_active Ceased
- 1994-02-25 WO PCT/FR1994/000210 patent/WO1994020108A1/fr active IP Right Grant
- 1994-02-25 JP JP6519649A patent/JPH08507509A/ja active Pending
- 1994-02-25 CZ CZ952259A patent/CZ285339B6/cs not_active IP Right Cessation
- 1994-02-25 KR KR1019950703733A patent/KR960700723A/ko not_active Application Discontinuation
- 1994-03-03 IL IL10884694A patent/IL108846A0/xx not_active IP Right Cessation
- 1994-03-03 IL IL10884594A patent/IL108845A0/xx unknown
- 1994-03-03 IL IL108844A patent/IL108844A/en not_active IP Right Cessation
- 1994-03-04 ZA ZA941530A patent/ZA941530B/xx unknown
- 1994-03-04 ZA ZA941525A patent/ZA941525B/xx unknown
-
1995
- 1995-02-28 US US08/396,106 patent/US5624945A/en not_active Expired - Lifetime
- 1995-08-28 NO NO953370A patent/NO307687B1/no not_active IP Right Cessation
- 1995-08-28 NO NO953372A patent/NO953372L/no unknown
- 1995-08-28 NO NO953371A patent/NO953371L/no unknown
-
1997
- 1997-01-23 GR GR960402768T patent/GR3022356T3/el unknown
-
2001
- 2001-05-31 GR GR20010400060T patent/GR3035957T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO953370L (no) | Anvendelse av riluzol ved behandling av neuro-AIDS | |
NO954427D0 (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
NO20005290D0 (no) | Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdom | |
BR9506552A (pt) | Método de inibição de integrase retroviral | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
ES2170377T3 (es) | Composicion que contiene quitosana. | |
NO307204B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader | |
CA2409379A1 (fr) | Utilisation du riluzole ou ses sels pour la prevention et le traitement de l'adrenoleucodystrophie | |
KR900007413A (ko) | 에이즈 발병방지, 치료제 및 그 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |